News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
413,712 Results
Type
Article (19551)
Company Profile (119)
Press Release (394033)
Multimedia
Podcasts (69)
Webinars (14)
Section
Business (121298)
Career Advice (717)
Deals (23651)
Drug Delivery (88)
Drug Development (56468)
Employer Resources (68)
FDA (9937)
Job Trends (8604)
News (214964)
Policy (20007)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (915)
Accelerated approval (26)
Adcomms (13)
Allergies (98)
Alliances (30277)
ALS (116)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (210)
Approvals (10238)
Artificial intelligence (327)
Autoimmune disease (106)
Automation (20)
Bankruptcy (226)
Best Places to Work (6610)
BIOSECURE Act (10)
Biosimilars (131)
Biotechnology (51)
Bladder cancer (120)
Brain cancer (45)
Breast cancer (379)
Cancer (3225)
Cardiovascular disease (251)
Career advice (641)
Career pathing (16)
CAR-T (204)
CDC (15)
Celiac Disease (1)
Cell therapy (501)
Cervical cancer (26)
Clinical research (49859)
Collaboration (1097)
Compensation (492)
Complete response letters (46)
COVID-19 (1287)
CRISPR (61)
C-suite (581)
Cystic fibrosis (90)
Data (4541)
Denatured (21)
Depression (86)
Diabetes (277)
Diagnostics (3310)
Digital health (21)
Diversity (5)
Diversity, equity & inclusion (20)
Drug discovery (170)
Drug pricing (139)
Drug shortages (24)
Duchenne muscular dystrophy (164)
Earnings (54181)
Editorial (33)
Employer branding (5)
Employer resources (61)
Events (60435)
Executive appointments (673)
FDA (12217)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (840)
Gene editing (129)
Generative AI (28)
Gene therapy (378)
GLP-1 (595)
Government (2273)
Grass and pollen (5)
Guidances (324)
Healthcare (8330)
HIV (37)
Huntington's disease (20)
IgA nephropathy (78)
Immunology and inflammation (135)
Immuno-oncology (34)
Indications (91)
Infectious disease (1433)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (63)
Intellectual property (201)
Interviews (100)
IPO (10969)
IRA (41)
Job creations (2321)
Job search strategy (554)
JPM (36)
Kidney cancer (13)
Labor market (39)
Layoffs (237)
Leadership (13)
Legal (4424)
Liver cancer (57)
Longevity (9)
Lung cancer (430)
Lymphoma (289)
Machine learning (27)
Management (23)
Manufacturing (567)
MASH (126)
Medical device (5654)
Medtech (5683)
Mergers & acquisitions (13493)
Metabolic disorders (768)
Multiple sclerosis (109)
NASH (16)
Neurodegenerative disease (175)
Neuropsychiatric disorders (56)
Neuroscience (1807)
Neurotech (1)
NextGen: Class of 2026 (2688)
Non-profit (1218)
Now hiring (18)
Obesity (354)
Opinion (200)
Ovarian cancer (124)
Pain (160)
Pancreatic cancer (164)
Parkinson's disease (189)
Partnered (18)
Patents (390)
Patient recruitment (353)
Peanut (26)
People (36349)
Pharmaceutical (66)
Pharmacy benefit managers (22)
Phase 1 (15109)
Phase 2 (21871)
Phase 3 (16977)
Pipeline (4081)
Policy (178)
Postmarket research (1642)
Preclinical (5904)
Press Release (32)
Prostate cancer (160)
Psychedelics (27)
Radiopharmaceuticals (193)
Rare diseases (586)
Real estate (3213)
Recruiting (25)
Regulatory (16284)
Reports (23)
Research institute (975)
Resumes & cover letters (89)
Rett syndrome (23)
RNA editing (10)
RSV (37)
Schizophrenia (116)
Series A (143)
Series B (107)
Service/supplier (4)
Sickle cell disease (74)
Special edition (11)
Spinal muscular atrophy (96)
Sponsored (24)
Startups (2014)
State (2)
Stomach cancer (11)
Supply chain (70)
Tariffs (72)
The Weekly (46)
Vaccines (437)
Venture capital (50)
Weight loss (217)
Women's health (38)
Worklife (9)
Date
Today (9)
Last 7 days (384)
Last 30 days (1303)
Last 365 days (20086)
2026 (2273)
2025 (20348)
2024 (23157)
2023 (26081)
2022 (33044)
2021 (34274)
2020 (32185)
2019 (23605)
2018 (17975)
2017 (20129)
2016 (18370)
2015 (22004)
2014 (16825)
2013 (13797)
2012 (14600)
2011 (15378)
2010 (14158)
Location
Africa (430)
Alabama (42)
Alaska (3)
Arizona (128)
Arkansas (6)
Asia (29519)
Australia (5923)
California (7173)
Canada (2377)
China (871)
Colorado (326)
Connecticut (345)
Delaware (210)
Europe (57042)
Florida (1163)
Georgia (156)
Hawaii (2)
Idaho (15)
Illinois (535)
India (59)
Indiana (339)
Iowa (2)
Japan (328)
Kansas (86)
Kentucky (24)
Louisiana (15)
Maine (46)
Maryland (854)
Massachusetts (5261)
Michigan (127)
Minnesota (315)
Mississippi (1)
Missouri (86)
Montana (13)
Nebraska (15)
Nevada (89)
New Hampshire (53)
New Jersey (2342)
New Mexico (11)
New York (2059)
North Carolina (999)
North Dakota (3)
Northern California (3485)
Ohio (172)
Oklahoma (6)
Oregon (25)
Pennsylvania (1509)
Puerto Rico (20)
Rhode Island (24)
South America (673)
South Carolina (50)
Southern California (2900)
Tennessee (113)
Texas (1095)
United States (26026)
Utah (164)
Virginia (205)
Washington D.C. (51)
Washington State (631)
West Virginia (3)
Wisconsin (60)
Wyoming (1)
413,712 Results for "telix pharmaceuticals limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Telix Full Year Results 2025 Investor Webcast Notification
February 4, 2026
·
5 min read
Press Releases
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
January 8, 2026
·
5 min read
Press Releases
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025
·
13 min read
Press Releases
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
January 20, 2026
·
15 min read
Press Releases
Telix to Participate in UBS and Jefferies Global Healthcare Conferences
November 5, 2025
·
5 min read
Deals
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.
ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed.
April 11, 2024
·
3 min read
Press Releases
Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain
October 22, 2025
·
8 min read
Press Releases
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
October 14, 2025
·
14 min read
Press Releases
Telix H1 2025 Results: Investor Webcast Notification
July 30, 2025
·
5 min read
Press Releases
Telix Reports $204M Revenue, Up 63% YOY
July 22, 2025
·
14 min read
1 of 41,372
Next
